Alpha Signal Monitor - Daily Market Briefing | December 25, 2025
Daily Market Research Report
December 25, 2025
Alpha Signal Monitor
Welcome to your daily pre-market briefing. This report provides key insights on market opportunities and analyst perspectives to help identify potential alpha signals.
Today's Coverage: - Gold ETF Outlook: Institutional perspectives on gold-backed ETFs - Stock Ratings: Latest analyst ratings and target prices for our watchlist - IPO Calendar: Upcoming initial public offerings and market debuts
Watchlist Stocks: AAPL, MSFT, GOOGL, AMZN, NVDA, META, TSLA, AVGO, TSM
This report is generated using advanced AI research capabilities with real-time market data access.
Street view: Gold ETF outlook into 2026
Trading Idea: Buy Rationale (TL;DR): Most top houses (Goldman, JPMorgan, Bank of America, UBS, Deutsche) are constructive into 2026 with gold price targets clustered around $4,500–$5,000/oz, citing persistent central‑bank buying, returning ETF inflows, de‑dollarization, and an easier Fed—suggesting continued upside for GLD/IAU/BAR despite near‑term volatility.
Gold set successive record highs into late December 2025 as rate‑cut expectations, geopolitical risk and a weaker USD met strong official‑sector and ETF demand. Strategists now see 2026 shaped by continued central‑bank accumulation and investment diversification, with banks lifting targets (e.g., GS $4,900 by Dec‑2026; JPM sees a push toward $5,000 by 4Q‑2026). UBS also highlights elevated official purchases and a reversal to ETF net buying.
Key Drivers - Robust official-sector (central bank) demand; UBS projects around 1,000t in 2025 with ongoing accumulation into 2026. - Re‑acceleration of ETF inflows after multi‑year outflows, supported by lower real rates and diversification demand. - Prospect of further Fed easing in 2026 and a softer USD, improving carry dynamics relative to cash/bonds. - Geopolitical and trade/tariff uncertainty sustaining safe‑haven bids and de‑dollarization flows. - Constrained mine supply response and limited scrap elasticity despite higher prices.
| Institution | Stance | Price View | Key Evidence | Last Update | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Bullish | $4,900/oz by Dec‑2026 (raised from $4,300) | Cites strong central‑bank demand and renewed Western ETF inflows; risks skewed to upside if private‑sector diversification exceeds modelled flows. | 2025-12-18 | - |
| Morgan Stanley | Constructive/Bullish | $4,500/oz by mid‑2026 (also $4,400 avg 2026 in MS Research note) | Sees continued ETF and central‑bank buying with a weaker USD; acknowledges volatility and softer jewelry demand near term. | 2025-10-31 | - |
| JP Morgan | Bullish | Toward $5,000/oz by 4Q‑2026; ~$5,400/oz by end‑2027 | Notes structural rebasing higher on official‑reserve diversification and investment demand; expects strong combined demand through 2026. | 2025-12-16 | - |
| Bank of America | Bullish | Path to $5,000/oz in 2026; ~ $4,400 average | Sees further upside as investment demand rises alongside high deficits and lower rates; flags risk of near‑term correction. | 2025-10-13 | - |
| Citigroup | Neutral/Cautious (near term) | 0–3m cut to $3,800/oz (from $4,000) as of Oct‑2025 | Trimmed short‑term targets on softer momentum and reduced immediate macro risk; medium‑term scenarios remain path‑dependent on tariffs and growth. | 2025-10-28 | - |
| UBS | Most Preferred/Bullish | Raised mid‑2026 target to $4,500/oz; prior base case $3,500/oz (Apr‑2025) | Highlights de‑dollarization, strong official buying (~1,000t 2025) and reversal to ETF net inflows; maintains gold as a strategic hedge in CIO asset allocation. | 2025-11-20 | - |
| HSBC | Bullish | As high as $5,000/oz in 2026; 2026 average raised to $4,600/oz | Sees bull market sustained into 1H‑2026 by geopolitical risk, policy uncertainty and rising public debt; expects high volatility. | 2025-10-17 | - |
| Deutsche Bank | Bullish | 2026 forecast raised to $4,450/oz; range $3,950–$4,950 | Points to persistent central‑bank demand and stabilizing ETF inflows creating a positive structural backdrop and higher floor. | 2025-11-26 | - |
Risk Considerations - A more hawkish‑than‑expected Fed path or upside surprises in real yields strengthening the USD. - A rapid easing of geopolitical/tariff tensions that unwinds safe‑haven demand and slows official purchases. - Central banks reducing or pausing reserve accumulation; reversal to ETF outflows. - Liquidity‑driven year‑end spikes retracing; elevated two‑way volatility and position squeezes. - Macro reflation without financial‑stability stress that rotates flows back to risk assets.
Position GLD/IAU/BAR as core hedges with a buy‑the‑dip bias into 2026; scale exposure and monitor real‑rate path, USD trend, central‑bank purchase data and ETF flow momentum for confirmation.
Stock Ratings — Street targets and ratings from GS, MS, JPM, BAC, Citi, WFC — As of 2025-12-25
Below are the latest publicly verifiable target prices/ratings from the requested institutions. Dates reflect the most recent research items we could access. Ratings mapped: Buy/Overweight/Outperform → Buy; Equal Weight/Neutral → Hold; Underweight/Underperform → Sell. Currency shown as published by the source.
AAPL - Apple Inc.
Most houses remain Buy; BAC’s October raise and MS’s December lift were notable.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $253 | 2025-05-24 | Maintained Buy with $253 PT. | https://www.investing.com/news/analyst-ratings/goldman-sachs-maintains-apple-stock-buy-rating-253-target-93CH-4062771 |
| Morgan Stanley | Buy | $315 | 2025-12-17 | Raised PT from $305; Overweight. | https://www.investing.com/news/analyst-ratings/morgan-stanley-raises-apple-stock-price-target-to-315-on-higher-revenue-93CH-4412022 |
| JP Morgan | Buy | $240 | 2025-06-03 | Maintained Overweight. | https://www.investing.com/news/analyst-ratings/jpmorgan-maintains-apple-stock-rating-with-240-price-target-4077532 |
| Bank of America | Buy | $320 | 2025-10-29 | Raised PT; long-term framework. | https://finance.yahoo.com/news/apple-stock-target-raised-bofa-135505743.html |
| Citigroup | Buy | $240 | 2025-07-11 | Maintained Buy post-WWDC cycle. | https://www.investing.com/news/analyst-ratings/citi-maintains-apple-stock-buy-rating-with-240-target-amid-iphone-demand-shifts-93CH-4131765 |
| Wells Fargo | Buy | $290 | 2025-10-21 | Maintained Overweight; PT raised. | https://www.gurufocus.com/news/3152412/aapl-wells-fargo-raises-price-target-to-290-maintains-overweight-rating-aapl-stock-news |
Consensus View - Rating: Buy, Target Price: $276.33 - 6/6 Buy equivalents; mean of listed PTs.
MSFT - Microsoft Corp.
Consensus Buy with several PT hikes tied to AI/Copilot/Azure momentum.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $550 | 2025-05-20 | Raised PT; AI strength. | https://www.investing.com/news/analyst-ratings/goldman-sachs-raises-microsoft-stock-price-target-to-550-4054324 |
| Morgan Stanley | Buy | $540 | 2025-01-22 | Overweight; trimmed from $548. | https://www.investing.com/news/analyst-ratings/morgan-stanley-cuts-microsoft-stock-target-overweight-rating-amid-concerns-3824238 |
| JP Morgan | Buy | $475 | 2025-05-01 | Overweight after FQ3 beat. | https://www.investing.com/news/analyst-ratings/jpmorgan-raises-microsoft-stock-price-target-to-475-4015871 |
| Bank of America | Buy | $480 | 2025-04-15 | Maintained Buy. | https://www.investing.com/news/analyst-ratings/bofa-cuts-microsoft-stock-price-target-to-480-maintains-buy-rating-93CH-3985464 |
| Citigroup | Buy | $690 | 2025-10-30 | Raised PT; Buy. | https://www.gurufocus.com/news/3172856/msft-sees-price-target-increase-to-690-by-citigroup-maintaining-buy-rating-msft-stock-news |
| Wells Fargo | Buy | $700 | 2025-10-30 | Overweight; PT raised from $675. | https://www.investing.com/news/analyst-ratings/microsoft-stock-price-target-raised-to-700-from-675-at-wells-fargo-93CH-4318741 |
Consensus View - Rating: Buy, Target Price: $572.50 - All six positive; average reflects AI-led optimism.
GOOGL - Alphabet Inc.
Broadly Buy; WFC remains Hold/Equal Weight.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $234 | 2025-09-03 | Reiterated Buy post-search case remedies. | https://www.investing.com/news/analyst-ratings/goldman-sachs-reiterates-buy-rating-on-alphabet-stock-amid-search-case-remedies-93CH-4221041 |
| Morgan Stanley | Buy | $210 | 2025-02-05 | Overweight; PT cut to $210. | https://www.investing.com/news/analyst-ratings/morgan-stanley-cuts-alphabet-stock-price-target-to-210-93CH-3849521 |
| JP Morgan | Buy | $300 | 2025-10-27 | Raised PT; Overweight. | https://www.investing.com/news/analyst-ratings/jpmorgan-raises-alphabet-stock-price-target-to-300-on-ai-strength-93CH-4309660 |
| Bank of America | Buy | $280 | 2025-10-20 | Raised PT on ad strength. | https://www.investing.com/news/analyst-ratings/bofa-securities-raises-alphabet-stock-price-target-to-280-on-ad-strength-93CH-4296307 |
| Citigroup | Buy | $200 | 2025-04-25 | Maintained Buy. | https://www.investing.com/news/analyst-ratings/citi-raises-alphabet-stock-price-target-to-200-maintains-buy-rating-4004059 |
| Wells Fargo | Hold | $268 | 2025-10-30 | Equal Weight; PT raised. | https://www.gurufocus.com/news/3171027/googl-wells-fargo-raises-alphabets-price-target-to-268-googl-stock-news |
Consensus View - Rating: Buy, Target Price: $248.67 - Five Buys, one Hold.
AMZN - Amazon.com Inc.
Buy skew; PTs cluster mid-$200s with MS and WFC higher.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $275 | 2025-10-03 | Raised PT; AWS/Ads drivers. | https://www.investing.com/news/analyst-ratings/goldman-sachs-raises-amazon-stock-price-target-to-275-on-aws-growth-outlook-93CH-4270016 |
| Morgan Stanley | Buy | $300 | - | Raised PT ahead of Q2’25 (reporting). | https://www.barrons.com/articles/amazon-stock-price-target-earnings-b8814a52 |
| JP Morgan | Buy | $225 | 2025-05-02 | Overweight maintained. | https://www.investing.com/news/analyst-ratings/jpmorgan-maintains-amazon-stock-overweight-rating-225-target-93CH-4020428 |
| Bank of America | Buy | $230 | 2025-05-02 | PT lifted to $230. | https://www.investing.com/news/analyst-ratings/bofa-lifts-amazon-stock-price-target-to-230-maintains-buy-rating-93CH-4018903 |
| Citigroup | Buy | $265 | 2025-07-22 | PT raised ahead of Q2; Buy. | https://it.investing.com/news/analyst-ratings/citi-alza-il-target-di-prezzo-del-titolo-amazon-a-265-grazie-alle-prospettive-di-crescita-di-aws-93CH-2912290 |
| Wells Fargo | Buy | $295 | 2025-12-02 | Overweight; PT raised. | https://www.investing.com/news/analyst-ratings/amazon-stock-price-target-raised-to-295-from-292-at-wells-fargo-93CH-4385725 |
Consensus View - Rating: Buy, Target Price: $265.00 - All six positive; average around mid-$260s.
NVDA - NVIDIA Corp.
All six positive; PTs span $150–$275+ with BAC/WFC at high end.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $250 | 2025-11-20 | Raised PT post-results. | https://www.investing.com/news/analyst-ratings/goldman-sachs-raises-nvidia-stock-price-target-to-250-on-ai-outlook-93CH-4369369 |
| Morgan Stanley | Buy | $170 | 2025-05-29 | Overweight; PT raised to $170. | https://www.investing.com/news/analyst-ratings/morgan-stanley-lifts-nvidia-stock-price-target-to-170-4069699 |
| JP Morgan | Buy | $170 | 2025-03-20 | Overweight reaffirmed. | https://www.investing.com/news/analyst-ratings/jpmorgan-maintains-nvidia-stock-overweight-rating-and-170-target-3938862 |
| Bank of America | Buy | $275 | 2025-12-11 | Top sector pick; PT maintained/raised during Nov–Dec updates. | https://www.investing.com/news/analyst-ratings/bofa-securities-reiterates-buy-rating-on-nvidia-stock-maintains-275-target-93CH-4402511 |
| Citigroup | Buy | $150 | 2025-05-20 | Maintained Buy; Computex takeaways. | https://www.investing.com/news/analyst-ratings/citi-maintains-nvidia-stock-buy-rating-150-price-target-93CH-4054315 |
| Wells Fargo | Buy | $265 | 2025-11-14 | Overweight; PT raised. | https://it.investing.com/news/analyst-ratings/wells-fargo-alza-il-target-di-prezzo-delle-azioni-nvidia-a-265-grazie-alle-prospettive-di-crescita-dellia-93CH-3098409 |
Consensus View - Rating: Buy, Target Price: $213.33 - Mean of listed PTs across six banks.
META - Meta Platforms Inc.
Strong Buy skew; PTs generally $750–$875; BAC at $810.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $815 | 2025-10-30 | PT trimmed from $870; Buy. | https://www.investing.com/news/analyst-ratings/goldman-sachs-lowers-meta-stock-price-target-to-815-on-investment-cycle-93CH-4317852 |
| Morgan Stanley | Buy | $750 | 2025-12-11 | Overweight; PT lowered from $820. | https://www.investing.com/news/analyst-ratings/meta-platforms-stock-price-target-lowered-to-750-by-morgan-stanley-93CH-4402248 |
| JP Morgan | Buy | $875 | 2025-07-31 | Raised PT; Overweight. | https://www.investing.com/news/analyst-ratings/meta-platforms-stock-price-target-raised-to-875-from-795-at-jpmorgan-4163780 |
| Bank of America | Buy | $810 | 2025-12-18 | Maintained Buy at $810. | https://www.investing.com/news/analyst-ratings/meta-stock-price-target-maintained-at-810-by-bofa-on-ai-potential-93CH-4414294 |
| Citigroup | Buy | $780 | 2025-03-28 | Maintained Buy. | https://www.investing.com/news/analyst-ratings/citi-maintains-meta-stock-buy-rating-780-price-target-93CH-3953860 |
| Wells Fargo | Buy | $837 | 2025-10-07 | Overweight; PT raised. | https://www.gurufocus.com/news/3133898/wells-fargo-raises-meta-platforms-meta-price-target-to-837-meta-stock-news |
Consensus View - Rating: Buy, Target Price: $811.17 - All six Buy equivalents; mean PT ~ $811.
TSLA - Tesla Inc.
Views diverge widely (JPM Sell vs. MS/BAC positive PTs; WFC Underweight).
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Hold | $400 | 2025-12-16 | Neutral; PT maintained as robotaxi testing expands. | https://www.investing.com/news/analyst-ratings/goldman-sachs-maintains-tesla-stock-rating-as-robotaxi-testing-begins-93CH-4409946 |
| Morgan Stanley | Buy | $410 | 2025-03-20 | Overweight; PT reduced from $430. | https://factandforecast.com/forecasts-market-data/stocks/tesla-tsla-forecast-accuracy/ |
| JP Morgan | Sell | $120 | 2025-03-12 | Underweight; delivery/margin concerns. | https://www.reuters.com/business/autos-transportation/jpmorgan-cuts-price-target-tesla-shares-brokerage-expects-lower-deliveries-2025-03-12/ |
| Bank of America | Hold | $471 | 2025-10-29 | Neutral; raised PT on SOTP. | https://www.investing.com/news/stock-market-news/tsla-is-the-leader-in-physical-ai-but-valuation-stretched-says-bofa-4316161 |
| Citigroup | - | - | - | - | - |
| Wells Fargo | Sell | $120 | 2025-10-23 | Underweight reiterated post-earnings. | https://www.investing.com/news/analyst-ratings/wells-fargo-reiterates-underweight-rating-on-tesla-stock-after-eps-miss-93CH-4303537 |
Consensus View - Rating: Hold, Target Price: $304.20 - Average of five available PTs; stance mixed across banks.
AVGO - Broadcom Inc.
Strong AI/custom silicon narrative; multiple recent PT increases (partial set shown).
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | - | - | - | - | - |
| Morgan Stanley | Buy | $270 | 2025-06-06 | Overweight; PT raised on AI growth. | https://www.investing.com/news/analyst-ratings/morgan-stanley-raises-broadcom-stock-price-target-citing-ai-growth-93CH-4084614 |
| JP Morgan | Buy | $400 | 2025-09-05 | Overweight; PT raised from $325. | https://www.investing.com/news/analyst-ratings/jpmorgan-raises-broadcom-stock-price-target-to-400-from-325-93CH-4226521 |
| Bank of America | Buy | $500 | 2025-12-12 | Top pick; AI backlog cited. | https://www.investing.com/news/analyst-ratings/broadcom-stock-price-target-raised-to-500-by-bofa-on-ai-growth-93CH-4405225 |
| Citigroup | - | - | - | - | - |
| Wells Fargo | - | - | - | - | - |
Consensus View - Rating: Buy, Target Price: $390.00 - Computed across available PTs (MS, JPM, BAC). Additional sources pending.
TSM - Taiwan Semiconductor Mfg. Co.
AI/advanced packaging driving repeated PT raises; partial set below (local currency).
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | TWD 1,370 | 2025-07-17 | Conviction Buy; raised from TWD 1,210. | https://www.investing.com/news/analyst-ratings/tsmc-price-target-raised-to-nt1370-by-goldman-sachs-on-ai-demand-93CH-4140356 |
| Morgan Stanley | - | - | - | - | - |
| JP Morgan | Buy | TWD 1,500 | 2025-03-05 | Overweight maintained. | https://www.investing.com/news/analyst-ratings/jpmorgan-maintains-tsmc-stock-overweight-twd1500-target-93CH-3908014 |
| Bank of America | - | - | - | - | - |
| Citigroup | - | - | - | - | - |
| Wells Fargo | - | - | - | - | - |
Consensus View - Rating: Buy, Target Price: TWD 1,435.00 - Average of GS and JPM local-currency targets; more banks to be added.
Highlights
- AAPL: BAC raised PT to $320 (2025-10-29) while MS lifted to $315 (2025-12-17); consensus Buy ~ $276.
- MSFT: WFC and Citi at the high end ($700 and $690); consensus Buy ~ $573.
- GOOGL: Five Buys, one Hold (WFC); consensus PT ~ $249.
- AMZN: Broad Buy with MS/WFC higher ($300/$295); consensus ~ $265.
- NVDA: All six positive; BAC/WFC top-end PTs ($275/$265).
- META: Consensus Buy; average PT ~ $811 with JPM at $875.
- TSLA: Split views — JPM $120 (Sell) vs. BAC $471 (Hold) and MS $410 (Buy); consensus Hold ~ $304.
- AVGO, TSM: Partial coverage included; remaining bank entries can be added on request.
Would you like me to complete the remaining entries for AVGO and TSM (Goldman, Citi, Wells Fargo; plus any missing items) and keep this updated on a schedule?
IPO Calendar
Timeframe: December 25, 2025 – January 25, 2026
As of December 25, 2025, no firm U.S. operating‑company IPOs are scheduled for the final week of December; calendars typically resume in early January after the holiday lull. Renaissance Capital’s latest week‑ahead update notes “no IPOs are currently scheduled,” consistent with seasonality. Looking into the coming month, the visible U.S. pipeline includes several newly filed or recently updated large deals that could launch roadshows once markets reopen (timing subject to SEC review and market conditions), including MiniMed (Medtronic’s Diabetes unit), Motive Technologies, Klook, and York Space Systems. Exchange operators also signal a constructive backdrop for 2026 activity after a stronger 2025: Nasdaq reported $46.65 billion raised from new listings through December 18 and sees a bigger year ahead for billion‑dollar IPOs.
Libera Gaming Operations, Inc. (LBRJ)
- Expected listing date: 2025-12-30 (tentative)
- Price range: US$5.00 – US$7.00 per share (preliminary)
- Shares offered: 1,000,000 shares (+150,000 over‑allotment)
- Exchange: NYSE American (application to list)
- Business summary: Japan‑based operator of pachinko gaming halls (11 locations as of March 15, 2024) with a complementary Tokyo‑focused real‑estate business; proceeds earmarked for expansion. Deal is a micro‑cap U.S. IPO; timing remains tentative.
- Notes: Date is not confirmed by SEC; some third‑party calendars show 2025‑12‑30. Exchange per F‑1 is NYSE American; other calendars show Nasdaq—treat as unconfirmed. Underwriter names not clearly identified in the accessible prospectus; a representative’s warrant is registered.
- Sources: SEC Form F‑1/A (preliminary prospectus) – Libera Gaming Operations., Renaissance Capital – Upcoming IPO calendar reference for LBRJ (unscheduled).
Motive Technologies, Inc. (MTVE)
- Exchange: NYSE (application to list)
- Lead underwriters: J.P. Morgan, Citigroup, Barclays, Jefferies, RBC Capital Markets, Citizens Capital Markets, KeyBanc Capital Markets, Société Générale, Wolfe | Nomura Alliance, William Blair, Canaccord Genuity, Needham & Company, Piper Sandler, Raymond James, Academy Securities
- Business summary: AI‑driven platform for ‘physical operations’—fleet management, driver safety, equipment monitoring, spend and workforce management—serving logistics, construction, energy and other field‑intensive sectors; filed an S‑1 on December 23, 2025.
- Notes: Share count and price range not yet set; timing subject to SEC review. Proposed ticker MTVE on NYSE per filing reports.
- Sources: SEC Form S‑1 – Motive Technologies (includes syndicate list)., Reuters coverage of filing and proposed ticker/exchange.
MiniMed Group, Inc. (Medtronic Diabetes) (MMED)
- Exchange: Nasdaq Global Select (application to list)
- Lead underwriters: Goldman Sachs, BofA Securities, Citigroup, Morgan Stanley, (additional joint bookrunners named in company release)
- Business summary: Medtronic’s Diabetes business (insulin pumps, continuous glucose monitors, Smart MDI system) filed to IPO as a first step in a planned separation; proceeds expected for general corporate purposes and to establish a standalone capital structure.
- Notes: S‑1 filed December 19, 2025; deal size/terms TBD and timing subject to SEC review and market conditions. Underwriter group per company announcement.
- Sources: SEC Form S‑1 – MiniMed Group, Inc., Company press release (PR Newswire/BioSpace) naming exchange and lead underwriters.
Klook Technology Limited (ADSs) (KLK)
- Exchange: NYSE (application to list; ADSs)
- Lead underwriters: Goldman Sachs, J.P. Morgan, Morgan Stanley
- Business summary: APAC travel‑experiences marketplace (activities, attractions, local services) seeking U.S. listing via ADSs; funds expected for growth and general corporate purposes.
- Notes: Filed Form F‑1 on November 10, 2025; timing and terms TBD pending SEC review.
- Sources: Company newsroom – F‑1 filing and proposed NYSE ticker KLK.
York Space Systems (YSS)
- Exchange: NYSE (application to list)
- Lead underwriters: Goldman Sachs, Jefferies, Wells Fargo Securities
- Business summary: Satellite manufacturer and defense‑space prime (S‑CLASS/LX‑CLASS/M‑CLASS platforms; SDA PWSA programs) filed an S‑1; proceeds to support growth and working capital.
- Notes: Filed November 2025; terms and launch timing not yet set.
- Sources: Company press release – S‑1 filing, proposed NYSE ticker YSS, and bookrunners., Reuters background on filing and financials.
IPO calendars are fluid. As of December 25, 2025, there are no firm U.S. operating‑company IPOs scheduled for the holiday week and early‑January slots often fill only days in advance. Micro‑cap offerings and SPACs may price on short notice, and all dates/terms remain subject to SEC effectiveness, market windows, and issuer decisions.
Sources
- Stock Ratings: https://factandforecast.com/forecasts-market-data/stocks/tesla-tsla-forecast-accuracy/, https://finance.yahoo.com/news/apple-stock-target-raised-bofa-135505743.html, https://it.investing.com/news/analyst-ratings/citi-alza-il-target-di-prezzo-del-titolo-amazon-a-265-grazie-alle-prospettive-di-crescita-di-aws-93CH-2912290, https://it.investing.com/news/analyst-ratings/wells-fargo-alza-il-target-di-prezzo-delle-azioni-nvidia-a-265-grazie-alle-prospettive-di-crescita-dellia-93CH-3098409, https://www.barrons.com/articles/amazon-stock-price-target-earnings-b8814a52, https://www.gurufocus.com/news/3133898/wells-fargo-raises-meta-platforms-meta-price-target-to-837-meta-stock-news, https://www.gurufocus.com/news/3152412/aapl-wells-fargo-raises-price-target-to-290-maintains-overweight-rating-aapl-stock-news, https://www.gurufocus.com/news/3171027/googl-wells-fargo-raises-alphabets-price-target-to-268-googl-stock-news, https://www.gurufocus.com/news/3172856/msft-sees-price-target-increase-to-690-by-citigroup-maintaining-buy-rating-msft-stock-news, https://www.investing.com/news/analyst-ratings/amazon-stock-price-target-raised-to-295-from-292-at-wells-fargo-93CH-4385725, https://www.investing.com/news/analyst-ratings/bofa-cuts-microsoft-stock-price-target-to-480-maintains-buy-rating-93CH-3985464, https://www.investing.com/news/analyst-ratings/bofa-lifts-amazon-stock-price-target-to-230-maintains-buy-rating-93CH-4018903, https://www.investing.com/news/analyst-ratings/bofa-securities-raises-alphabet-stock-price-target-to-280-on-ad-strength-93CH-4296307, https://www.investing.com/news/analyst-ratings/bofa-securities-reiterates-buy-rating-on-nvidia-stock-maintains-275-target-93CH-4402511, https://www.investing.com/news/analyst-ratings/broadcom-stock-price-target-raised-to-500-by-bofa-on-ai-growth-93CH-4405225, https://www.investing.com/news/analyst-ratings/citi-maintains-apple-stock-buy-rating-with-240-target-amid-iphone-demand-shifts-93CH-4131765, https://www.investing.com/news/analyst-ratings/citi-maintains-meta-stock-buy-rating-780-price-target-93CH-3953860, https://www.investing.com/news/analyst-ratings/citi-maintains-nvidia-stock-buy-rating-150-price-target-93CH-4054315, https://www.investing.com/news/analyst-ratings/citi-raises-alphabet-stock-price-target-to-200-maintains-buy-rating-4004059, https://www.investing.com/news/analyst-ratings/goldman-sachs-lowers-meta-stock-price-target-to-815-on-investment-cycle-93CH-4317852, https://www.investing.com/news/analyst-ratings/goldman-sachs-maintains-apple-stock-buy-rating-253-target-93CH-4062771, https://www.investing.com/news/analyst-ratings/goldman-sachs-maintains-tesla-stock-rating-as-robotaxi-testing-begins-93CH-4409946, https://www.investing.com/news/analyst-ratings/goldman-sachs-raises-amazon-stock-price-target-to-275-on-aws-growth-outlook-93CH-4270016, https://www.investing.com/news/analyst-ratings/goldman-sachs-raises-microsoft-stock-price-target-to-550-4054324, https://www.investing.com/news/analyst-ratings/goldman-sachs-raises-nvidia-stock-price-target-to-250-on-ai-outlook-93CH-4369369, https://www.investing.com/news/analyst-ratings/goldman-sachs-reiterates-buy-rating-on-alphabet-stock-amid-search-case-remedies-93CH-4221041, https://www.investing.com/news/analyst-ratings/jpmorgan-maintains-amazon-stock-overweight-rating-225-target-93CH-4020428, https://www.investing.com/news/analyst-ratings/jpmorgan-maintains-apple-stock-rating-with-240-price-target-4077532, https://www.investing.com/news/analyst-ratings/jpmorgan-maintains-nvidia-stock-overweight-rating-and-170-target-3938862, https://www.investing.com/news/analyst-ratings/jpmorgan-maintains-tsmc-stock-overweight-twd1500-target-93CH-3908014, https://www.investing.com/news/analyst-ratings/jpmorgan-raises-alphabet-stock-price-target-to-300-on-ai-strength-93CH-4309660, https://www.investing.com/news/analyst-ratings/jpmorgan-raises-broadcom-stock-price-target-to-400-from-325-93CH-4226521, https://www.investing.com/news/analyst-ratings/jpmorgan-raises-microsoft-stock-price-target-to-475-4015871, https://www.investing.com/news/analyst-ratings/meta-platforms-stock-price-target-lowered-to-750-by-morgan-stanley-93CH-4402248, https://www.investing.com/news/analyst-ratings/meta-platforms-stock-price-target-raised-to-875-from-795-at-jpmorgan-4163780, https://www.investing.com/news/analyst-ratings/meta-stock-price-target-maintained-at-810-by-bofa-on-ai-potential-93CH-4414294, https://www.investing.com/news/analyst-ratings/microsoft-stock-price-target-raised-to-700-from-675-at-wells-fargo-93CH-4318741, https://www.investing.com/news/analyst-ratings/morgan-stanley-cuts-alphabet-stock-price-target-to-210-93CH-3849521, https://www.investing.com/news/analyst-ratings/morgan-stanley-cuts-microsoft-stock-target-overweight-rating-amid-concerns-3824238, https://www.investing.com/news/analyst-ratings/morgan-stanley-lifts-nvidia-stock-price-target-to-170-4069699, https://www.investing.com/news/analyst-ratings/morgan-stanley-raises-apple-stock-price-target-to-315-on-higher-revenue-93CH-4412022, https://www.investing.com/news/analyst-ratings/morgan-stanley-raises-broadcom-stock-price-target-citing-ai-growth-93CH-4084614, https://www.investing.com/news/analyst-ratings/tsmc-price-target-raised-to-nt1370-by-goldman-sachs-on-ai-demand-93CH-4140356, https://www.investing.com/news/analyst-ratings/wells-fargo-reiterates-underweight-rating-on-tesla-stock-after-eps-miss-93CH-4303537, https://www.investing.com/news/stock-market-news/tsla-is-the-leader-in-physical-ai-but-valuation-stretched-says-bofa-4316161, https://www.reuters.com/business/autos-transportation/jpmorgan-cuts-price-target-tesla-shares-brokerage-expects-lower-deliveries-2025-03-12/
Disclaimer
This research report is for informational purposes only and does not constitute investment advice. All information is sourced from publicly available data and should be verified independently. Past performance does not guarantee future results.
Generated on: 2025-12-25 at 11:23 UTC
Source: Alpha Signal Monitor - Automated Research System
Contact: For questions about this report, please contact your Alpha Signal Monitor administrator.
Powered by Alpha Signal Monitor | Market Intelligence Through AI